630 related articles for article (PubMed ID: 16328478)
1. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis.
Qi H; Xiao L; Lingyun W; Ying T; Yi-Zhi L; Shao-Xu Y; Quan P
Ann Hematol; 2006 Feb; 85(2):95-101. PubMed ID: 16328478
[TBL] [Abstract][Full Text] [Related]
2. [Expression of insulin-like growth factor receptor type I in marrow nucleated cells from hematologic malignancies and its anti-apoptotic effect].
He Q; Li X; Tao Y; Liu YZ; Yang LP; Ying SX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):483-7. PubMed ID: 15972147
[TBL] [Abstract][Full Text] [Related]
3. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
Wu LY; Li X; Chang CK; Ying SX; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrows.
Mundle SD; Mativi BY; Bagai K; Feldman G; Cheema P; Gautam U; Reza S; Cartlidge JD; Venugopal P; Shetty V; Gregory SA; Robin E; Rifkin S; Shah R; Raza A
Int J Hematol; 1999 Aug; 70(2):83-90. PubMed ID: 10497846
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous intramedullary apoptosis is present in disorders other than myelodysplasia.
Irvine AE; Magill MK; Somerville LE; McMullin MF
Exp Hematol; 1998 May; 26(5):435-9. PubMed ID: 9590661
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic cells and clonally expanded cytotoxic T cells in bone marrow trephines of patients with myelodysplastic syndrome.
Pülhorn H; Herrmann M; Harms H; Jung A; Baumann I
Histopathology; 2012 Aug; 61(2):200-11. PubMed ID: 22690734
[TBL] [Abstract][Full Text] [Related]
7. Expression of Toll-like receptor 9 in bone marrow cells of myelodysplastic syndromes is down-regulated during transformation to overt leukemia.
Kuninaka N; Kurata M; Yamamoto K; Suzuki S; Umeda S; Kirimura S; Arai A; Nakagawa Y; Suzuki K; Kitagawa M
Exp Mol Pathol; 2010 Apr; 88(2):293-8. PubMed ID: 20132814
[TBL] [Abstract][Full Text] [Related]
8. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
9. Expression and function of c-kit receptor in bone marrow mononuclear cells of patients with myelodysplastic syndromes.
Shao Z; Zhang H; Chen G; Wang L; Li K; Zhang Y; Li L; Sun J
Chin Med J (Engl); 2001 May; 114(5):481-5. PubMed ID: 11780408
[TBL] [Abstract][Full Text] [Related]
10. [The type I insulin-like growth factor receptor highly expressed in clonal cells of myelodysplastic syndromes].
He Q; Li X; Zhang Z; Zhang QX; Yang LP
Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):744-7. PubMed ID: 22339909
[TBL] [Abstract][Full Text] [Related]
11. [The implications of the biological indices examination of bone marrow cells in myelodysplastic syndromes].
Zhang F; Hao Y; Pang W
Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):528-32. PubMed ID: 11769678
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
[TBL] [Abstract][Full Text] [Related]
13. [Study on apoptosis in myelodysplastic syndromes by DNA in situ end labelling combined with APAAP].
Li X; Pu Q; Liu Y; Shi J; Tao Y; Chang C; Jiang Q; Huang W
Zhonghua Xue Ye Xue Za Zhi; 2002 Jan; 23(1):27-9. PubMed ID: 12015085
[TBL] [Abstract][Full Text] [Related]
14. [Apoptotic characteristics of CD34 positive cells in myelodysplastic syndromes].
Li X; Pu Q; Liu YZ; Tao Y; Ying SX; Jiang QY; Shi J
Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):355-7. PubMed ID: 12941189
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of IGF-IR in malignant clonal cells in bone marrow of myelodysplastic syndromes.
He Q; Li X; Zhang Z; Zhang Q; Xu F; Yang L; Tao Y; Liu Y
Cancer Invest; 2010 Dec; 28(10):983-8. PubMed ID: 20569071
[TBL] [Abstract][Full Text] [Related]
16. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
17. Deviation of type I and type II T cells and its negative effect on hematopoiesis in myelodysplastic syndrome.
Wu L; Li X; Chang C; Ying S; He Q; Pu Q
Int J Lab Hematol; 2008 Oct; 30(5):390-9. PubMed ID: 19046314
[TBL] [Abstract][Full Text] [Related]
18. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.
Invernizzi R; Travaglino E; Benatti C; Malcovati L; Della Porta M; Cazzola M; Ascari E
Eur J Haematol; 2006 Jun; 76(6):494-501. PubMed ID: 16529600
[TBL] [Abstract][Full Text] [Related]
19. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
[TBL] [Abstract][Full Text] [Related]
20. Evi-1 and MDS1-Evi-1 genes in pathogenesis of myelodysplastic syndromes and post-MDS acute myeloid leukemia.
Xu K; Wang L; Hao Y; Shao Z; Meng Q; Li K; Chao H; Tang K; Wang L
Chin Med J (Engl); 1999 Dec; 112(12):1112-8. PubMed ID: 11721451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
